# Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study

> **NCT06830408** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 250 (actual)

## Conditions studied

- mCRPC

## Interventions

- **DRUG:** radionuclide therapy with 177Lu-PSMA-I&T

## Key facts

- **NCT ID:** NCT06830408
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-06
- **Primary completion:** 2024-11-12
- **Final completion:** 2025-01-13
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2025-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06830408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06830408, "Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06830408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*